Tetracycline Treatment Tolerability Trial

Summary

Randomized, double-blind, placebo-controlled study (with a one-week washout period) where subjects receive either 3 months of tetracycline or 3 months of placebo. After the 3 month primary endpoint, in the follow-up period, patients will be assigned to the alternate treatment for 3 months with blind maintained.

Timeline

Start

2022-11-02

Primary completion

2026-06-09

Completion

2026-06-09

Drugs

Indications